Martin Schmiady

ORCID: 0000-0003-0210-7904
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Cardiac Structural Anomalies and Repair
  • Aortic Disease and Treatment Approaches
  • Mechanical Circulatory Support Devices
  • Congenital Heart Disease Studies
  • Infective Endocarditis Diagnosis and Management
  • Cardiac and Coronary Surgery Techniques
  • Aortic aneurysm repair treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Arrest and Resuscitation
  • Transplantation: Methods and Outcomes
  • Tissue Engineering and Regenerative Medicine
  • Coronary Artery Anomalies
  • Cardiac tumors and thrombi
  • Organ Transplantation Techniques and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Atherosclerosis and Cardiovascular Diseases
  • Pulmonary Hypertension Research and Treatments
  • Electrospun Nanofibers in Biomedical Applications
  • Venous Thromboembolism Diagnosis and Management
  • Trauma Management and Diagnosis
  • Kawasaki Disease and Coronary Complications
  • Vascular anomalies and interventions
  • Sirtuins and Resveratrol in Medicine
  • Cardiac pacing and defibrillation studies

University Hospital of Zurich
2018-2025

University Children's Hospital Zurich
2014-2024

Zurich Heart House
2021-2024

University of Zurich
2020-2023

Roberto Lorusso Maria Elena De Piero Silvia Mariani Michele Di Mauro Thierry Folliguet and 95 more Fabio Silvio Taccone Luigi Camporota Justyna Swol Dominik Wiedemann Mirko Belliato Lars Mikael Broman Alain Vuylsteke Yigal Kassif Anna Mara Scandroglio Vito Fanelli Philippe Gaudard Stéphane Ledot Julian M. Barker Udo Boeken Sven Maier Alexander Kersten Bart Meyns Matteo Pozzi Finn Møller Pedersen Peter Schellongowski Kaan Kırali Nicholas Barrett Jordi Riera Thomas Mueller Jan Bělohlávek Roberto Lorusso Maria Elena De Piero Silvia Mariani Michele Di Mauro Thierry Folliguet Fabio Silvio Taccone Luigi Camporota Justyna Swol Dominik Wiedemann Mirko Belliato Lars Mikael Broman Alain Vuylsteke Yigal Kassif Anna Mara Scandroglio Vito Fanelli Philippe Gaudard Stéphane Ledot Julian M. Barker Udo Boeken Sven Maier Alexander Kersten Bart Meyns Matteo Pozzi Finn Møller Pedersen Peter Schellongowski Kaan Kırali Nicholas Barrett Jordi Riera Thomas Mueller Jan Bělohlávek Valeria Lo Coco Iwan C.C. van der Horst Bas C. T. van Bussel Ronny M. Schnabel Thijs Delnoij Gil Bolotin Ferdinando Luca Lorini Martin Schmiady David Schibilsky Mariusz Kowalewski Luis Fernando Pinto Pedro Eduardo Silva И. А. Корнилов Aaron Blandino Ortíz Leen Vercaemst Simon J. Finney Peter P. Roeleveld Matteo Di Nardo Felix Hennig Marta Velia Antonini Mark Davidson Tim Jones Thomas Staudinger Peter Mair Juliane Kilo Christoph Krapf Kathrin Erbert Andreas Peer Nikolaos Bonaros Florian Kotheletner Niklas Krenner Mag Liana Shestakova Greet Hermans Dieter Dauwe Philippe Meersseman Bernard Stockman Leda Nobile Olivier Lhereux Alexandre Nrasseurs Jacques Creuter

10.1016/s2213-2600(22)00403-9 article FR The Lancet Respiratory Medicine 2022-11-16

The lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and its shedding product [soluble LOX-1 (sLOX-1)] are implicated in atherosclerotic cardiovascular disease (ASCVD) pathogenesis. Herein, we examined the relationship of sLOX-1 with both fatal events plaque progression patients acute coronary syndromes (ACS).Plasma was assessed at baseline ACS chronic syndrome (CCS) prospectively recruited multicentre SPUM-ACS study, sex- age-matched healthy subjects serving as additional...

10.1093/eurheartj/ehac143 article EN European Heart Journal 2022-03-08

Decellularized pulmonary homografts (DPH) have shown excellent results for valve replacement. However, controlled multicentre studies are lacking to date.Prospective European trial evaluating DPH Matched comparison of bovine jugular vein (BJV) conduits and cryopreserved (CH) considering patient age, type heart defect previous procedures.In total, 121 patients (59 female) were prospectively enrolled (August 2014-December 2016), age 21.3 ± 14.4 years, diameter 24.4 2.8 mm. No adverse events...

10.1093/ejcts/ezz054 article EN cc-by-nc European Journal of Cardio-Thoracic Surgery 2019-02-08

Enhancing SIRT1 activity exerts beneficial cardiovascular effects. In diabetes, plasma levels are reduced. We aimed to investigate the therapeutic potential of chronic recombinant murine (rmSIRT1) supplementation alleviate endothelial and vascular dysfunction in diabetic mice (db/db).Left internal mammary arteries obtained from patients undergoing coronary artery bypass grafting with or without a diagnosis diabetes were assayed for protein levels. Twelve-week-old male db/db db/+ controls...

10.1093/cvr/cvad102 article EN cc-by Cardiovascular Research 2023-07-04

Abstract OBJECTIVES Decellularized aortic homografts (DAH) may provide an additional valve replacement option for young patients due to their potential overcome the high early failure rate of conventional allogenic and xenogenic prostheses. METHODS A prospective, European Union-funded, single-arm, multicentre, safety study was conducted in 8 centres evaluating non-cryopreserved DAH replacement. RESULTS One hundred forty-four (99 male) were prospectively enrolled between October 2015 2018,...

10.1093/ejcts/ezaa100 article EN cc-by-nc European Journal of Cardio-Thoracic Surgery 2020-03-06

Fueled by the global surge in aging, atherosclerotic cardiovascular disease reached pandemic dimensions putting affected individuals at enhanced risk of myocardial infarction, stroke, and premature death. Atherosclerosis is a systemic driven wide spectrum factors, including cholesterol, pressure, disturbed flow. Although all arterial beds encounter similar atherogenic milieu, development atheromatous lesions occurs discontinuously across vascular system. Indeed, internal mammary artery...

10.1161/atvbaha.121.316256 article EN Arteriosclerosis Thrombosis and Vascular Biology 2021-06-10

Early results from the prospective ESPOIR Trial have indicated excellent for pulmonary valve replacement using decellularized homografts (DPH).A 5-year analysis of patients was performed to provide an insight into midterm DPH performance. and Registry were matched with cryopreserved (CH) considering patient age, type heart defect previous procedures present overall experience DPH.A total 121 (59 female) prospectively enrolled (8/2014-12/2016), median age 16.5 years (interquartile range...

10.1093/ejcts/ezac219 article EN cc-by-nc European Journal of Cardio-Thoracic Surgery 2022-03-22

Abstract OBJECTIVES Decellularized aortic homografts (DAH) were introduced in 2008 as a further option for paediatric valve replacement (AVR). METHODS Prospective, multicentre follow-up of all patients receiving DAH AVR 8 European centres. RESULTS A total 143 implanted between February and 2023 137 children (106 male, 74%) with median age 10.8 years (interquartile range 6.6–14.6). Eighty-four (59%) had undergone previous cardiac operations 24 (17%) AVR. The diameter was 21 mm 19–23)....

10.1093/ejcts/ezae112 article EN cc-by European Journal of Cardio-Thoracic Surgery 2024-03-25

Large-bore catheter aspiration embolectomy reduces thrombus burden and right ventricle strain improves haemodynamics after pulmonary embolism (PE). Sparse data are available for patients with high-risk PE contraindications to thrombolysis or failure, particularly if veno-arterial extracorporal membrane oxygenation (VA-ECMO) is required.All acute undergoing FlowTriever® percutaneous VA-ECMO circulatory support (or standby) at the University Hospital Zurich between April 2021 August 2022 were...

10.1093/ehjacc/zuad014 article EN other-oa European Heart Journal Acute Cardiovascular Care 2023-02-24

Abstract Background The reconstruction of heart valves provides substantial benefits, particularly in the pediatric population. We present our experience using decellularized extracellular matrix ( dECM , CorMatrix ® ) for aortic valve procedures. Methods retrospectively reviewed case histories 6 patients (aged from 2 months ‐ 14 years) who underwent surgery severe stenosis (n = 4) or regurgitation 2). Aortic repair was performed on all as a leaflet replacement extension. Follow‐ups were...

10.1111/xen.12341 article EN Xenotransplantation 2017-09-22

Options for paediatric aortic valve replacement (AVR) are limited if repair is not feasible. Results of Ross procedures inferior to adult results, and mechanical AVR imposes constant anticoagulation with the inherent risks.The study design was a prospective, multicentre follow-up all patients receiving decellularized homografts (DAHs) in 8 European centres.A total 106 children (77 boys) were operated (mean age 10.1 ± 4.8 years, DAH diameter 20.5 3.8 mm). A 60 (57%) had undergone previous...

10.1093/ejcts/ezaa119 article EN cc-by-nc European Journal of Cardio-Thoracic Surgery 2020-03-16

The current standard for donor heart preservation consists of cold organ storage in three sequential plastic bags. This technique can cause freezing injuries the as temperature inside transport box is not monitored routinely. SherpaPak™ Cardiac Transport System (CTS) (Paragonix Technologies, Cambridge, MA, USA) aims to resolve this problem by maintaining a controlled between 4 and 8 °C. study reports first single-centre experience Switzerland with innovative single-use disposable...

10.21037/jtd-21-1175 article EN Journal of Thoracic Disease 2021-11-24

Oral anticoagulation prior to emergency surgery is associated with an increased risk of perioperative bleeding, especially when this therapy cannot be discontinued or reversed in time. The goal study was analyse the impact different oral anticoagulants on outcome patients who underwent for acute type A aortic dissection (ATAAD).This a single-centre retrospective treated at time ATAAD. Outcomes new anticoagulant (NOAC) were compared respective outcomes Coumadin. Additionally, survival...

10.1093/icvts/ivac037 article EN cc-by Interactive Cardiovascular and Thoracic Surgery 2022-02-08

The pediatric population has benefited greatly by the evolution of ventricular assist devices (VADs) leading to miniaturization. Device design like HeartWare® VAD allows for implantation in smaller patients or even as an implantable biventricular device.A ten-year-old female patient (body surface area: 1.02 m2, 27 kg) waiting 7 months heart transplantation was admitted intensive care unit due terminal failure. Transthoracal echocardiography revealed failure with estimated ejection fraction...

10.5301/ijao.5000463 article EN The International Journal of Artificial Organs 2016-01-01

Background: Cerebral embolic protection devices (CEPDs) have emerged as a mechanical barrier to prevent debris from reaching the cerebral vasculature, potentially reducing stroke incidence. Bovine aortic arch (BAA) is most common variant and represents challenge anatomy for CEPD insertion during transcatheter valve replacement (TAVR). Methods: Cohort study reporting SentinelTM Protection System insertion’s feasibility safety in 165 adult patients submitted transfemoral TAVR procedure April...

10.3390/jcm9124118 article EN Journal of Clinical Medicine 2020-12-20

Aortic valve-sparing root replacement (AVSRR) is a technically demanding procedure. In experienced centers it offers excellent short- and long-term results, making the procedure an attractive alternative for aortic especially in young patients. The aim of this study was to analyze results AVSRR using David operation our institution over last 25 years.This single-center retrospective analysis outcomes operations performed teaching not running large AVSRR-program. Pre-, intra- postoperative...

10.3389/fcvm.2023.1104149 article EN cc-by Frontiers in Cardiovascular Medicine 2023-03-10

Abstract For decades, bovine jugular vein conduits (BJV) and classic cryopreserved homografts have been the two most widely used options for pulmonary valve replacement (PVR) in congenital heart disease. More recently, decellularized (DPH) provided an alternative avenue PVR. Matched comparison of patients who received DPH PVR with considering patient age group, type defect, previous procedures. 319 were matched to BJV patients; mean was 15.3 (SD 9.5) years versus 19.1 (12.4) ( p = 0.001)....

10.1007/s10561-023-10082-4 article EN cc-by Cell and Tissue Banking 2023-03-14
Coming Soon ...